You are viewing: Canada ECMO Machines Market analysis
Part of: ECMO Machines Market (Global)

The Canada ECMO Machines Market was valued at $40.08 Million in 2025 and projected to reach to $53.51 Million by 2030, representing a compound annual growth rate of 6.0%. Canada's ECMO machines market demonstrates resilient growth driven by increasing prevalence of cardiac and respiratory complications, coupled with rising healthcare expenditure on advanced life support technologies.

Canada ECMO Machines Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Canada ECMO Machines Market Trends and Insights

  • This represents a compound annual growth rate (CAGR) of 6.0%, reflecting increasing adoption of extracorporeal membrane oxygenation technology across Canadian healthcare institutions.
  • Canada's advanced healthcare infrastructure and rising prevalence of cardiac and respiratory conditions are driving demand for ECMO devices in critical care settings. The Canadian market benefits from strong government healthcare funding, well-established hospital networks, and growing clinical recognition of ECMO's life-saving potential in severe cases.
  • Between 2025 and 2030, Canada is expected to see expanded ECMO program development in major medical centers, particularly in provinces with leading cardiac and transplant programs.
  • Technological advancements and improved reimbursement policies are positioning Canada as a key market for ECMO machine manufacturers in North America..

Key Market Statistics

  • CAGR (2025-2030) 6.0% CAGR
  • Market Size, 2025 ~USD 40.08 Million
  • Forecast, 2030 ~USD 53.51 Million
  • Country Canada

Canada ECMO Machines Market Overview

Market Growth Trajectory :

Canada's ECMO machines market is projected to grow from $40.08 million in 2025 to $53.51 million by 2030, representing a steady 6.0% CAGR, outpacing the global growth rate of 5.8%.

Advanced Healthcare Infrastructure :

Canada's robust healthcare system and well-established medical device adoption framework support accelerated ECMO technology integration across major teaching hospitals and critical care centers.

Regional Market Consolidation :

Leading Canadian healthcare institutions in Ontario, Quebec, and British Columbia are driving demand for ECMO systems, with increasing investment in cardiac and respiratory support capabilities.

Regulatory Environment :

Health Canada's streamlined approval processes for critical care devices and alignment with international standards facilitate faster market entry and technology adoption for ECMO manufacturers.

Canada ECMO Machines Market Dynamics

  • The Canadian healthcare system's emphasis on critical care infrastructure modernization and the adoption of extracorporeal membrane oxygenation in major medical centers are key growth catalysts.
  • Over the forecast period through 2030, market expansion will be supported by growing clinical evidence supporting ECMO efficacy, increased physician training programs, and enhanced reimbursement policies.
  • Provincial health authorities' commitment to upgrading intensive care units with state-of-the-art equipment positions Canada as a significant growth market within North America..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Canada's ECMO machines market is valued at $40.08 million in 2025 and is forecast to grow to $53.51 million by 2030.
    • Canada's market is growing at a 6.0% CAGR, driven by advanced healthcare infrastructure and increasing critical care demand.
    • Major Canadian medical centers are expanding ECMO programs, particularly in cardiac and transplant specialties.
    • Technological innovation and improved reimbursement in Canada are accelerating ECMO adoption across provinces.

    ECMO Machines Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) (Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.8% from 2025 to 2030
    Largest Segment ADULT PATIENTS (Patient Type)
    Market Size Base Year (Billions) ~USD 0.65 (2025)
    Revenue Forecast (Billions) ~USD 0.86 (2030)
    Segments Covered Product, Type, Modality, Patient Type, Application, End User

    Canada ECMO Machines Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Components
    • Machines

    By Type

    • Accessories
    • Cannulas
    • Controllers
    • Oxygenators
    • Pumps

    By Modality

    • Arteriovenous Ecmo
    • Venoarterial Ecmo
    • Venovenous Ecmo

    By Patient Type

    • Adult Patients
    • Neonates
    • Pediatric Patients

    By Application

    • Cardiac Applications
    • Extracorporeal Cardiopulmonary Resuscitation (Ecpr)
    • Respiratory Applications

    By End User

    • Academic & Research Institutions
    • Hospitals
    • Specialty Clinics

    CANADA: ECMO MACHINES MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    ACADEMIC & RESEARCH INSTITUTIONS11.1911.6212.0912.5913.1413.7514.4115.124.6
    HOSPITALS43.7745.8848.1950.6553.3856.3759.6263.185.6
    SPECIALTY CLINICS7.47.617.848.098.378.6799.363.6
    TOTAL62.3665.1168.1271.3374.978.7983.0387.665.2

    Target Audience

    • Medical Device Manufacturers : ECMO equipment producers need Canadian market data to assess market potential, identify growth opportunities, develop localized strategies, and establish distribution partnerships with healthcare providers.
    • Healthcare System Administrators : Hospital executives and provincial health authorities require market insights to justify capital investments in ECMO technology, benchmark against peer institutions, and optimize critical care resource allocation.
    • Investment & Private Equity Firms : Investors evaluating healthcare technology opportunities in Canada need comprehensive market sizing, growth forecasts, and competitive analysis to inform investment decisions and portfolio strategy.
    • Medical Device Distributors : Canadian distributors and medical equipment suppliers require market intelligence to identify demand hotspots, negotiate supplier agreements, and develop effective sales and marketing campaigns.
    • Healthcare Consultants & Analysts : Industry consultants advising healthcare organizations need Canada-specific ECMO market data to support strategic recommendations, feasibility studies, and technology adoption roadmaps.

    Key Companies in the Canada ECMO Machines Market

    CompanyHQOwnershipStrongest segments
    GETINGESwedenPublic CompanyAcute Care Therapies,Surgical Workflows,Life Science,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
    FRESENIUS MEDICAL CARE AGGermanyPublic CompanyDialysis services (outpatient and in-hospital ESRD/acute),Dialysis machines, cyclers, and water treatment systems,Dialysis consumables and solutions,
    LIVANOVA PLCUnited KingdomPublic CompanyCardiopulmonary (heart-lung machines, oxygenators, autotransfusion, perfusion tubing, cannula, services),Neuromodulation (VNS Therapy for epilepsy and depression, aura6000 development),
    NIPROJapanPublic CompanyDialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products, functional products,Pharmaceutical-Related (CDMO for injectables and oral drugs, kit products),
    WEIGAO GROUP CO., LTD.ChinaPublic CompanyMedical Device Products (infusion, clinical nursing, perioperative, urinary, rehab, extracorporeal circulation),Orthopedic Products (spine, joint, trauma, sports medicine, bone repair, spinal endoscope),Pharma Packaging Products (prefilled systems, packaging consumables, automatic drug delivery),
    ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
    MICROPORT SCIENTIFIC CORPORATIONChinaPublic CompanyCardiovascular Devices,Orthopedics Devices,Cardiac Rhythm Management,

    GETINGE

    Getinge is a Swedish public company founded in 1904 that employs 11,754 people and operates in the medical technology sector.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees specializing in medical devices and healthcare solutions.

    TERUMO CORPORATION

    Terumo Corporation is a Japanese public company established in 1921 with 30,591 employees, operating in the medical device and healthcare industry.

    FRESENIUS MEDICAL CARE AG

    Fresenius Medical Care AG is a German public company founded in 1996 with 108,165 employees, providing dialysis and renal care services globally.

    LIVANOVA PLC

    LivaNova PLC is a United Kingdom-based public company founded in 2015 with 3,300 employees, focused on neuromodulation and cardiac surgery solutions.

    NIPRO

    Nipro is a Japanese public company established in 1947 with 38,593 employees, manufacturing medical devices and pharmaceutical products.

    WEIGAO GROUP CO., LTD.

    Weigao Group Co., Ltd. is a Chinese public company founded in 1988 with 13,307 employees, specializing in medical device manufacturing.

    ABBOTT

    Abbott is a United States-based public company founded in 1888 with 115,000 employees, operating across diagnostics, medical devices, nutrition, and pharmaceuticals.

    MICROPORT SCIENTIFIC CORPORATION

    MicroPort Scientific Corporation is a Chinese public company established in 1998 with 6,547 employees, developing and manufacturing medical devices.

    Reasons to Buy this Report

    • Market Size & Forecast Data : Access precise Canadian market valuations ($40.08M in 2025, $53.51M in 2030) with detailed year-over-year projections to support strategic planning and investment decisions.
    • Competitive Landscape Analysis : Identify key ECMO manufacturers operating in Canada, their market share, product portfolios, and competitive positioning within the Canadian healthcare ecosystem.
    • Regional Growth Drivers : Understand Canada-specific factors including healthcare policy changes, provincial funding initiatives, clinical adoption rates, and institutional procurement patterns driving market expansion.
    • Regulatory & Reimbursement Insights : Gain clarity on Health Canada approval pathways, provincial reimbursement frameworks, and healthcare funding mechanisms that influence ECMO market dynamics and pricing strategies.
    • Strategic Market Entry Planning : Leverage Canada-focused market intelligence to develop targeted go-to-market strategies, identify partnership opportunities with hospitals and distributors, and optimize resource allocation.

    Frequently asked questions

    What is the current size of Canada's ECMO machines market?

    Canada's ECMO machines market is estimated at $40.08 million in 2025, with verified data showing strong market fundamentals across Canadian healthcare institutions.

    What is the projected market size for ECMO machines in Canada by 2030?

    Canada's ECMO machines market is forecast to reach $53.51 million by 2030, representing a 6.0% compound annual growth rate over the five-year period.

    What is driving growth in Canada's ECMO machines market?

    Growth in Canada is driven by advanced healthcare infrastructure, rising cardiac and respiratory disease prevalence, expanded ECMO program development, and improved clinical outcomes recognition.

    Which Canadian regions are leading ECMO adoption?

    Major Canadian medical centers in provinces with leading cardiac and transplant programs, particularly in Ontario, Quebec, and British Columbia, are spearheading ECMO program expansion.

    How does Canada's ECMO market growth compare to North America?

    Canada's 6.0% CAGR reflects strong market fundamentals, positioning Canada as a significant contributor to North American ECMO market growth through 2030.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size of the ECMO machines market. Exhaustive secondary research was done to collect information on the ECMO market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ECMO market.

    Secondary Research

    This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ECMO market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the ECMO market. Primary sources from the demand side included hospitals, academic & research institutions, specialty clinics, researchers, lab technicians, purchase managers, and stakeholders in corporate & government bodies.

    The following is a breakdown of the primary respondents:

    ECMO Machines Market

    Note 1: C-level primaries include CEOs, COOs, and CTOs.

    Note 2: Others include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ECMO market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    ECMO Machines Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ECMO machines and components. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    An ECMO machine acts as an artificial heart and lung for a patient whose heart or lungs cannot provide enough blood flow or oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs do not work. The goal of ECMO is to let the heart and lungs recover while the patient is supported by the ECMO machine.

    Stakeholders

    • Manufacturers of ECMO Machine Products and Related Devices
    • Suppliers and Distributors of ECMO Machine Devices
    • Hospitals, Clinics, and Medical Colleges
    • Medical Device Procurement Agencies
    • Government Bodies/Municipal Corporations
    • Business Research and Consulting Service Providers
    • Venture Capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the oxygen concentrators market based on product, modality, patient type, application, end user, and region  
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall oxygen concentrators market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the oxygen concentrators market in six regions, namely, North America (US and Canada), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East & Africa, and GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full ECMO Machines Market Report

    Full forecast, segment splits, and company analysis for all ECMO Machines Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status